RPRX fundamentals
An in-depth look to Royalty Pharma plc operating, investing, and financing activities
RPRX free cash flow for Q3 24 is 715.1 M USD. For 2023, RPRX free cash flow was 3.03 B USD and operating cash flow was 3.03 B USD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM